Search research articles
Contact Us
Filters
Showing results (781-790 of 825) with videos related to
Page
of 83
Sort By:
Drug and Alcohol Dependence
|
December 3, 2023
A preliminary randomized controlled trial of repetitive transcranial magnetic stimulation applied to the left dorsolateral prefrontal cortex in treatment seeking participants with cannabis use disorder
Gregory L Sahlem, Bohye Kim, Nathaniel L Baker, et al.
International Journal of Radiation Oncology, Biology, Physics
|
June 7, 2011
Intensity-modulated radiation therapy in oropharyngeal carcinoma: effect of tumor volume on clinical outcomes
Benjamin H Lok, Jeremy Setton, Nicola Caria, et al.
Medrxiv : the Preprint Server for Health Sciences
|
July 28, 2023
A Preliminary Investigation Of Repetitive Transcranial Magnetic Stimulation Applied To The Left Dorsolateral Prefrontal Cortex In Treatment Seeking Participants With Cannabis Use Disorder
Gregory L Sahlem, Bohye Kim, Nathaniel L Baker, et al.
Pain Medicine (Malden, Mass.)
|
February 17, 2021
Providing Epidemiological Data in Lumbar Spine Imaging Reports Did Not Affect Subsequent Utilization of Spine Procedures: Secondary Outcomes from a Stepped-Wedge Randomized Controlled Trial
Pradeep Suri, Eric N Meier, Laura S Gold, et al.
Oral Oncology
|
April 26, 2023
Post-operative PET/CT improves the detection of early recurrence of squamous cell carcinomas of the oral cavity
Yao Yu, Heiko Schöder, Kaveh Zakeri, et al.
The New England Journal of Medicine
|
October 23, 2023
Phase 3 Trial of Selpercatinib in Advanced <i>RET</i>-Mutant Medullary Thyroid Cancer
Julien Hadoux, Rossella Elisei, Marcia S Brose, et al.
Lancet (London, England)
|
December 4, 2023
Imetelstat in patients with lower-risk myelodysplastic syndromes who have relapsed or are refractory to erythropoiesis-stimulating agents (IMerge): a multinational, randomised, double-blind, placebo-controlled, phase 3 trial
Uwe Platzbecker, Valeria Santini, Pierre Fenaux, et al.
CA: a Cancer Journal for Clinicians
|
October 28, 2022
Consensuses, controversies, and future directions in treatment deintensification for human papillomavirus-associated oropharyngeal cancer
Jung Julie Kang, Yao Yu, Linda Chen, et al.
Journal of Neuro-Oncology
|
February 17, 2022
The survival outcomes of molecular glioblastoma IDH-wildtype: a multicenter study
Andres Ramos-Fresnedo, Michael W Pullen, Carlos Perez-Vega, et al.
The Lancet. Oncology
|
January 21, 2023
Radiotherapy and paclitaxel plus pazopanib or placebo in anaplastic thyroid cancer (NRG/RTOG 0912): a randomised, double-blind, placebo-controlled, multicentre, phase 2 trial
Eric J Sherman, Jonathan Harris, Keith C Bible, et al.
Page
of 83
Search research articles
Search
Showing results (781-790 of 825) with videos related to
Sort By:
Page
of 83
Drug and Alcohol Dependence
|
December 3, 2023
A preliminary randomized controlled trial of repetitive transcranial magnetic stimulation applied to the left dorsolateral prefrontal cortex in treatment seeking participants with cannabis use disorder
Gregory L Sahlem, Bohye Kim, Nathaniel L Baker, et al.
International Journal of Radiation Oncology, Biology, Physics
|
June 7, 2011
Intensity-modulated radiation therapy in oropharyngeal carcinoma: effect of tumor volume on clinical outcomes
Benjamin H Lok, Jeremy Setton, Nicola Caria, et al.
Medrxiv : the Preprint Server for Health Sciences
|
July 28, 2023
A Preliminary Investigation Of Repetitive Transcranial Magnetic Stimulation Applied To The Left Dorsolateral Prefrontal Cortex In Treatment Seeking Participants With Cannabis Use Disorder
Gregory L Sahlem, Bohye Kim, Nathaniel L Baker, et al.
Pain Medicine (Malden, Mass.)
|
February 17, 2021
Providing Epidemiological Data in Lumbar Spine Imaging Reports Did Not Affect Subsequent Utilization of Spine Procedures: Secondary Outcomes from a Stepped-Wedge Randomized Controlled Trial
Pradeep Suri, Eric N Meier, Laura S Gold, et al.
Oral Oncology
|
April 26, 2023
Post-operative PET/CT improves the detection of early recurrence of squamous cell carcinomas of the oral cavity
Yao Yu, Heiko Schöder, Kaveh Zakeri, et al.
The New England Journal of Medicine
|
October 23, 2023
Phase 3 Trial of Selpercatinib in Advanced <i>RET</i>-Mutant Medullary Thyroid Cancer
Julien Hadoux, Rossella Elisei, Marcia S Brose, et al.
Lancet (London, England)
|
December 4, 2023
Imetelstat in patients with lower-risk myelodysplastic syndromes who have relapsed or are refractory to erythropoiesis-stimulating agents (IMerge): a multinational, randomised, double-blind, placebo-controlled, phase 3 trial
Uwe Platzbecker, Valeria Santini, Pierre Fenaux, et al.
CA: a Cancer Journal for Clinicians
|
October 28, 2022
Consensuses, controversies, and future directions in treatment deintensification for human papillomavirus-associated oropharyngeal cancer
Jung Julie Kang, Yao Yu, Linda Chen, et al.
Journal of Neuro-Oncology
|
February 17, 2022
The survival outcomes of molecular glioblastoma IDH-wildtype: a multicenter study
Andres Ramos-Fresnedo, Michael W Pullen, Carlos Perez-Vega, et al.
The Lancet. Oncology
|
January 21, 2023
Radiotherapy and paclitaxel plus pazopanib or placebo in anaplastic thyroid cancer (NRG/RTOG 0912): a randomised, double-blind, placebo-controlled, multicentre, phase 2 trial
Eric J Sherman, Jonathan Harris, Keith C Bible, et al.
Page
of 83